CE IVD real-time PCR kit for detection of CYP2C9 polymorphisms (*2A, *13, HapB3, c2846A>T) according to CPIC and DPWG guidelines. Enables personalized dosing of warfarin and other CYP2C9-metabolized medications.
Manufactured by
GENERI BIOTECH s.r.o.
Hradec Králové - Pražské Předměstí, Czech Republic
GENERI BIOTECH s.r.o. is a Czech biotechnological company focused on research and development, manufacturing and selling of own proprietary products: the CE IVD kits based on molecular genetic methods, Life Sciences products and Oligonucleotides. In addition, GENERI BIOTECH s.r.o. also run testing facilities for both public and GLP/GMP tests, typically for CROs in the field of drug development. GENERI BIOTECH s.r.o. was established in 1995, originally as a facility for production of oligonucleotides. The synthesis of oligonucleotides has long been the basis of the company's activities. Since 2010, however, in addition to oligo synthesis, we have also focused on the development and production of our own IVD kits and products for Life Science. Since then, our IVD portfolio has been growing steadily, covering not only hematological diagnostics, but also pharmacogenetics, genetics, microbiology and oncology, within the market segment of laboratory diagnostics in human medicine. The production at GB is certified according to IVDR Regulation (EU) 2017/746 of the European Parliament and of the Council ( in vitro diagnostics), EN ISO 13485:2016 ( in vitro diagnostics) and EN ISO 9001:2016 (oligonucleotides and life science products).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 7 relevant products
Shenzhen Uni-medica Technology Co., Ltd
China · 2 relevant products
HymonBio Co., Ltd.
China · 3 relevant products
27 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 101 closest product alternatives
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Specialized gene detection kit for analyzing CYP2D6 genetic variations to predict drug metabolism and response. This test enables precision medicine by guiding drug selection and dosing for individual patients.
Shenzhen Uni-medica Technology Co., Ltd · China
A diagnostic kit for detecting CYP2C19 gene polymorphisms in human samples to guide personalized medication therapy.
HymonBio Co., Ltd. · China
In vitro diagnostic kit for detecting CYP2C9 and VKORC1 gene polymorphisms to guide warfarin dosing and reduce adverse drug reactions. Enables pharmacogenomic-based anticoagulation therapy optimization in patients requiring warfarin treatment.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products